Moderna | MRNA - Stock


Moderna reported $280M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
Agios Pharmaceuticals USD 35.75M 665K Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
Amgen USD 6.22B 34M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Biogen USD 2.38B 435.3M Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Celltrion KRW 126B 3.06B Mar/2026
Cspc Pharmaceutical CNY 3.09B 219.95M Dec/2025
Divis Laboratories Ltd INR 39.54B 7.18B Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Incyte USD 112.54M 3.08M Jun/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Kangmei Pharma CNY 2.38B 73.9M Mar/2026
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Moderna USD 280M 134M Jun/2026
Organigram Holdings CAD 135.16M 2.45M Mar/2026
Pharma Mar EUR 49.53M 3.59M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Qiagen NV USD 309.61M 7.72M Mar/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
Sartorius EUR 831.9M 4.8M Jun/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
United Therapeutics USD 193.8M 15.5M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 6.28B 553.86M Mar/2026